HK1059215A1 - Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome - Google Patents

Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome

Info

Publication number
HK1059215A1
HK1059215A1 HK04101910A HK04101910A HK1059215A1 HK 1059215 A1 HK1059215 A1 HK 1059215A1 HK 04101910 A HK04101910 A HK 04101910A HK 04101910 A HK04101910 A HK 04101910A HK 1059215 A1 HK1059215 A1 HK 1059215A1
Authority
HK
Hong Kong
Prior art keywords
mucositis
behcet
stomatitis
syndrome
treatment
Prior art date
Application number
HK04101910A
Other languages
English (en)
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Publication of HK1059215A1 publication Critical patent/HK1059215A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physiology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK04101910A 2000-07-28 2004-03-16 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome HK1059215A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001732A IT1318649B1 (it) 2000-07-28 2000-07-28 Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
PCT/EP2001/008303 WO2002009637A2 (en) 2000-07-28 2001-07-18 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome

Publications (1)

Publication Number Publication Date
HK1059215A1 true HK1059215A1 (en) 2004-06-25

Family

ID=11445589

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04101910A HK1059215A1 (en) 2000-07-28 2004-03-16 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome

Country Status (26)

Country Link
US (1) US20020173485A1 (de)
EP (1) EP1313489B1 (de)
JP (1) JP2004505028A (de)
KR (1) KR100761051B1 (de)
CN (1) CN1198625C (de)
AR (1) AR030068A1 (de)
AT (1) ATE289512T1 (de)
AU (2) AU2002212113B2 (de)
BR (1) BRPI0112962B8 (de)
CA (1) CA2424346C (de)
CZ (1) CZ301461B6 (de)
DE (1) DE60109044T2 (de)
ES (1) ES2236324T3 (de)
HK (1) HK1059215A1 (de)
HR (1) HRP20030046B1 (de)
IT (1) IT1318649B1 (de)
MX (1) MXPA03000712A (de)
MY (1) MY130477A (de)
NO (1) NO329574B1 (de)
NZ (1) NZ523832A (de)
PL (1) PL204397B1 (de)
PT (1) PT1313489E (de)
RU (1) RU2272636C2 (de)
UA (1) UA79075C2 (de)
WO (1) WO2002009637A2 (de)
ZA (1) ZA200300712B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314049T3 (es) 2001-02-15 2009-03-16 Access Pharmaceuticals, Inc. Formulaciones liquidas para la prevencion y el tratamiento de enfermedades y trastornos de la mucosa.
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
BR0309890A (pt) 2002-05-09 2005-05-10 Medigenes Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
US20060234977A1 (en) * 2003-01-23 2006-10-19 Gina Wenham Antiviral compostion comprising a sulphated glucose polymer and a bacteriostatic agent
GB0312485D0 (en) * 2003-05-30 2003-07-09 Dodson & Horrell Horse food composition
ITMI20031291A1 (it) 2003-06-25 2004-12-26 Ricerfarma Srl Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
AU2003265624B2 (en) * 2003-08-21 2011-03-31 Abeona Therapeutics Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2008027904A2 (en) * 2006-08-28 2008-03-06 Rexaderm, Inc. Dry wound dressing and drug delivery system
KR100758636B1 (ko) * 2006-12-19 2007-09-13 고려대학교 산학협력단 생체 점막 점착성 고분자 접합체 및 이의 제조방법
PL2214679T3 (pl) 2007-11-13 2019-09-30 Meritage Pharma, Inc. Kompozycje kortykosteroidów
US20090123390A1 (en) 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
GB0813589D0 (en) * 2008-07-24 2008-09-03 Sinclair Pharmaceuticals Ltd Composition
PL2435021T3 (pl) * 2009-05-25 2014-03-31 Sofar Swiss Sa Zastosowanie połączenia glikozoaminoglikanowego o stałych proporcjach i kompozycji do żucia zawierającej wspomniane połączenie o stałych proporcjach
EP2557947A1 (de) 2010-04-14 2013-02-20 Altria Client Services Inc. Vorgeformtes rauchloses tabakprodukt
JP2013542250A (ja) * 2010-11-12 2013-11-21 コルゲート・パーモリブ・カンパニー オーラルケア製品ならびにその使用方法および製造方法
ES2388281B1 (es) 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
ITMI20110954A1 (it) * 2011-05-26 2012-11-27 Professional Dietetics Srl Combinazioni per il trattamento delle mucositi vaginali o rettali
US10799548B2 (en) * 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
EP3079656B8 (de) 2013-10-16 2020-02-26 Quest Products, LLC Behandlung von schleimhautläsionen mit aus einer befestigten pastille bereitgestellter hyaluronsäure
CN105342987A (zh) * 2015-12-04 2016-02-24 亚飞（上海）生物医药科技有限公司 一种凝胶及其制备方法和应用
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
JP6281968B1 (ja) * 2016-07-27 2018-02-21 株式会社リタファーマ 口腔粘膜貼付材及びその製造方法
IT201600079773A1 (it) * 2016-07-29 2018-01-29 Matteo Bevilacqua Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.
CN106176863A (zh) * 2016-08-04 2016-12-07 陈广圣 一种医用抗菌剂
CN107802641A (zh) * 2016-09-09 2018-03-16 李明典 口腔软组织(牙龈、粘膜)抗发炎酸痛剂
EP3459368A1 (de) * 2017-09-20 2019-03-27 Geophyt S.r.L. Lebensmittelintegrator für antineoplastische therapien
CN109331023A (zh) * 2018-11-12 2019-02-15 沈阳药科大学 甘草次酸的医药用途
KR102475125B1 (ko) 2019-08-07 2022-12-07 고려대학교 산학협력단 일산화질소 복합체를 포함하는 구강 점막염 치료용 조성물 및 구강 점막염 치료제
US20220362166A1 (en) * 2019-10-25 2022-11-17 Mucocort Ab Treatment of inflammatory condition in mucous membrane or skin
IT202100011879A1 (it) * 2021-05-10 2022-11-10 Aurora Biofarma S R L Composizione orale per il trattamento delle esofagiti

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA82361B (en) * 1981-02-06 1982-12-29 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity
GB2092442B (en) * 1981-02-06 1984-02-08 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity containing glycyrrhetinic acid or a derivative thereof
JPS6117510A (ja) * 1984-07-03 1986-01-25 Toyobo Co Ltd 口腔粘膜適用徐放性ニフエジピン製剤
JPS6440423A (en) * 1987-08-05 1989-02-10 Kyukyu Yakuhin Kogyo Kk Patch for mucosa in oral cavity
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
IT1240316B (it) * 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
JPH09169652A (ja) * 1995-12-18 1997-06-30 Lion Corp 水性液状組成物
JPH10182390A (ja) * 1996-12-25 1998-07-07 Lion Corp 口腔用組成物
JP2000178185A (ja) * 1998-12-18 2000-06-27 Lion Corp 口腔粘膜付着型徐放性錠剤

Also Published As

Publication number Publication date
CN1198625C (zh) 2005-04-27
ZA200300712B (en) 2004-02-09
EP1313489B1 (de) 2005-02-23
CZ301461B6 (cs) 2010-03-10
AU1211302A (en) 2002-02-13
AU2002212113B2 (en) 2006-01-12
DE60109044T2 (de) 2005-07-21
UA79075C2 (uk) 2007-05-25
DE60109044D1 (de) 2005-03-31
NO20030411D0 (no) 2003-01-27
BRPI0112962B8 (pt) 2021-05-25
PL204397B1 (pl) 2010-01-29
CA2424346A1 (en) 2002-02-07
IT1318649B1 (it) 2003-08-27
NO20030411L (no) 2003-01-27
PT1313489E (pt) 2005-05-31
CA2424346C (en) 2010-03-09
HRP20030046A2 (en) 2004-04-30
HRP20030046B1 (en) 2011-08-31
BR0112962B1 (pt) 2013-12-31
ES2236324T3 (es) 2005-07-16
MXPA03000712A (es) 2004-11-01
KR20030069979A (ko) 2003-08-27
BR0112962A (pt) 2003-06-24
EP1313489A2 (de) 2003-05-28
CN1474700A (zh) 2004-02-11
WO2002009637A3 (en) 2002-12-05
NO329574B1 (no) 2010-11-15
AR030068A1 (es) 2003-08-13
US20020173485A1 (en) 2002-11-21
ITMI20001732A1 (it) 2002-01-28
PL362921A1 (en) 2004-11-02
KR100761051B1 (ko) 2007-10-04
WO2002009637A2 (en) 2002-02-07
RU2272636C2 (ru) 2006-03-27
ATE289512T1 (de) 2005-03-15
MY130477A (en) 2007-06-29
NZ523832A (en) 2003-09-26
JP2004505028A (ja) 2004-02-19
ITMI20001732A0 (it) 2000-07-28

Similar Documents

Publication Publication Date Title
HRP20030046A2 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
HUP0402113A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
IL172695A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
HUP0104496A3 (en) Compositions comprising 1,1,1,3,3-pentafluorobutane and use of said compositions
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
IL112205A0 (en) Curcumin, analogues of curcumin and novel uses thereof
HUP0103851A3 (en) Factor viia inhibitors, process for their preparation, their use and pharmaceutical compositions comprising thereof
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
HUP0103265A3 (en) Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use
HUP0102255A3 (en) Vla-4 inhibitor omepupa-v, pharmaceutical compositions comprising thereof and their use
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
IL158671A0 (en) Benzyloxy derivatives and pharmaceutical compositions containing the same
EP1257255A4 (de) Therapeutisches produkt, dessen gebrauch und herstellung
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
HUP0301506A3 (en) Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and behcet's syndrome
HUP0203275A3 (en) 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants
HUP9903649A3 (en) Taxane derivatives, the preparation thereof and medical formulations containing them
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
SI1313489T1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
HUP0002154A3 (en) Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE NAME OF APPLICANT FROM SINCLAIR PHARMA S.R.L. TO SINCLAIR PHARMACEUTICALS LIMITED

PE Patent expired

Effective date: 20210717